| Hans-Günter Meyer-Thompson | Cannabis als Medizin
Delta-9-tetrahydrocannabinol modulates pain sensitivity among persons receiving opioid agonist therapy for opioid use disorder: A within-subject, randomized, placebo-controlled laboratory study.
Delta-9-tetrahydrocannabinol modulates pain sensitivity among persons receiving opioid agonist therapy for opioid use disorder: A within-subject, randomized, placebo-controlled laboratory study.
De Aquino JP, Meyerovich J, Xie CZ, Ranganathan M, Compton P, Pittman B, Rogan M, Sofuoglu M.
Addict Biol. 2023 Sep;28(9):e13317. doi: 10.1111/adb.13317. PMID: 37644897; PMCID: PMC10468603.
Abstract